Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-26

Clinical Trial Update: An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial evaluating oral R115866 for facial acne has completed, reporting results on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R115866 (R115866)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne | Phase 2 | Status: COMPLETED